388 related articles for article (PubMed ID: 32719668)
1. Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.
Loubet P; Ranfaing J; Dinh A; Dunyach-Remy C; Bernard L; Bruyère F; Lavigne JP; Sotto A
Front Microbiol; 2020; 11():1509. PubMed ID: 32719668
[TBL] [Abstract][Full Text] [Related]
2. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
Asadi Karam MR; Habibi M; Bouzari S
Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
[TBL] [Abstract][Full Text] [Related]
3. Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.
O'Brien VP; Hannan TJ; Nielsen HV; Hultgren SJ
Microbiol Spectr; 2016 Feb; 4(1):. PubMed ID: 26999391
[TBL] [Abstract][Full Text] [Related]
4. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.
Zalewska-Piątek BM; Piątek RJ
Acta Biochim Pol; 2019 May; 66(2):129-138. PubMed ID: 31136644
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Effect of Propolis and Antibiotics on Uropathogenic
Lavigne JP; Ranfaing J; Dunyach-Rémy C; Sotto A
Antibiotics (Basel); 2020 Oct; 9(11):. PubMed ID: 33120958
[TBL] [Abstract][Full Text] [Related]
7. Understanding the potential of lactobacilli in recurrent UTI prevention.
Vagios S; Hesham H; Mitchell C
Microb Pathog; 2020 Nov; 148():104544. PubMed ID: 33010368
[TBL] [Abstract][Full Text] [Related]
8. Non-Antibiotic Prophylaxis for Urinary Tract Infections.
Beerepoot M; Geerlings S
Pathogens; 2016 Apr; 5(2):. PubMed ID: 27092529
[TBL] [Abstract][Full Text] [Related]
9. Cranberry Consumption Against Urinary Tract Infections: Clinical Stateof- the-Art and Future Perspectives.
Mantzorou M; Giaginis C
Curr Pharm Biotechnol; 2018; 19(13):1049-1063. PubMed ID: 30520372
[TBL] [Abstract][Full Text] [Related]
10. The anti-virulence effect of cranberry active compound proanthocyanins (PACs) on expression of genes in the third-generation cephalosporin-resistant
Samarasinghe S; Reid R; Al-Bayati M
Antimicrob Resist Infect Control; 2019; 8():181. PubMed ID: 31832181
[TBL] [Abstract][Full Text] [Related]
11. [Non-antibiotic prophylaxis for recurrent urinary-tract infections].
Beerepoot MA; ter Riet G; Verbon A; Nys S; de Reijke TM; Geerlings SE
Ned Tijdschr Geneeskd; 2006 Mar; 150(10):541-4. PubMed ID: 16566416
[TBL] [Abstract][Full Text] [Related]
12. Current clinical status on the preventive effects of cranberry consumption against urinary tract infections.
Vasileiou I; Katsargyris A; Theocharis S; Giaginis C
Nutr Res; 2013 Aug; 33(8):595-607. PubMed ID: 23890348
[TBL] [Abstract][Full Text] [Related]
13. Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) against the virulence of uropathogenic Escherichia coli.
Ranfaing J; Dunyach-Remy C; Louis L; Lavigne JP; Sotto A
Sci Rep; 2018 Jul; 8(1):10706. PubMed ID: 30013052
[TBL] [Abstract][Full Text] [Related]
14. Natural therapeutics for urinary tract infections-a review.
Das S
Futur J Pharm Sci; 2020; 6(1):64. PubMed ID: 33215041
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic
Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
mBio; 2017 Oct; 8(5):. PubMed ID: 29066548
[TBL] [Abstract][Full Text] [Related]
16. Therapies in early development for the treatment of urinary tract inflammation.
Zacchè MM; Giarenis I
Expert Opin Investig Drugs; 2016; 25(5):531-40. PubMed ID: 26934616
[TBL] [Abstract][Full Text] [Related]
17. Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by
Zalewska-Piątek B; Piątek R
Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32517088
[TBL] [Abstract][Full Text] [Related]
18. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
[TBL] [Abstract][Full Text] [Related]
19. Treating urinary tract infections due to MDR E. coli with Isothiocyanates - a phytotherapeutic alternative to antibiotics?
Mutters NT; Mampel A; Kropidlowski R; Biehler K; Günther F; Bălu I; Malek V; Frank U
Fitoterapia; 2018 Sep; 129():237-240. PubMed ID: 30031115
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.
Galtier M; De Sordi L; Maura D; Arachchi H; Volant S; Dillies MA; Debarbieux L
Environ Microbiol; 2016 Jul; 18(7):2237-45. PubMed ID: 26971586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
